Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
20 24 Search
2025
Current advancements in PD-L1 modulation by CMTM6 in malignant tumors
Oncologie
2024
CMTM6 deletion affects chemoresistance and macrophage M2 polarization in colorectal cancer cells
BIOCELL
2024
CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway
Functional & Integrative Genomics
2023
High expression of CMTM6 is a risk factor for poor prognosis of gastrointestinal tumors: A meta-analysis
Asian Journal of Surgery
2023
Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
Cancer Immunology Research
2023
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
PeerJ
2023
Construction of stable membranal CMTM6-PD-L1 full-length complex to evaluate the PD-1/PD-L1-CMTM6 interaction and develop anti-tumor anti-CMTM6 nanobody
Acta Pharmacologica Sinica
2022
Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
Frontiers in Genetics
2022
CMTM6, a potential immunotherapy target
Journal of Cancer Research and Clinical Oncology
2022
CMTM6 as a master regulator of PD-L1
Cancer Immunology, Immunotherapy
2022
Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
BMC Cancer
2022
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Cell Death & Disease
2022
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
OncoImmunology
2022
CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
Cancer Management and Research
2022
The clinical and prognostic significance of CMTM6/PD-L1 in oncology
Clinical and Translational Oncology
2022
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
Frontiers in Immunology
2021
Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
Cancers
2021
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma
Journal of Cancer Research and Clinical Oncology
2021
Identification of Key Circulating Exosomal microRNAs in Gastric Cancer
Frontiers in Oncology
Additional cited-by details will be shown when available from Crossref